PMCT
PharmaCountry
+ Create
EN
Demands
Home
Products
Services
Jobs
Seekers
No categories for this tab
Retry
Regulatory Updates | Pharmacountry Insights
Home
/
Insights
/
Regulatory Updates
Regulatory Updates
FDA, EMA, TGA and global regulatory developments
#Nisoldipine
×
Daily News
Market Analysis
Research & Reports
Regulatory Updates
UPDATED
Regulatory Updates
Sep 9, 2026
•
3 min read
FDA Approves Mylan Nisoldipine Extended‑Release Tablets (ANDA 079051) – Discontinued Products
The FDA approved labeling for Mylan's discontinued Nisoldipine extended‑release tablets (20 mg, 30 mg, 40 mg) under ANDA 079051.